Amryt Pharma, a biopharmaceutical company focused on rare and orphan diseases, has appointed Kieran Rooney, as Vice President of Strategic Alliances and Licensing.In the announcement on Wednesday, Amryt’s first chair, CEO Joe Wiley welcomed Rooney to the senior management team, giving him the responsibility for assessing new acquisition and in-licencing opportunities according to the company’s strategy to acquire, develop and commercialise products to enhance the lives of patients with rare and orphan diseases. “We are excited to continue our buildout of critical leadership roles across the organization as we progress our broadening commercial stage pipeline to the benefit of patients with rare and orphan diseases,” Wiley said.
Dr. Rooney has over 25 years of experience in the biopharmaceutical industry, with significant expertise in business development and commercial strategy. Before joining Amryt, he founded Halo BioConsulting, a global healthcare advisory services firm focusing on business alliances and management consulting. Prior to that, Dr. Rooney worked as a consultant for the UK Government and held business development roles at companies including Smith & Nephew, F2G Limited, Pharsight Corporation, and MDS Pharma Services.